Literature DB >> 11413103

Methotrexate: a useful alternative in Crohn's disease?

A B Hawthorne1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11413103      PMCID： PMC1728367          DOI： 10.1136/gut.49.1.9

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

1.  A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.

Authors:  B G Feagan; R N Fedorak; E J Irvine; G Wild; L Sutherland; A H Steinhart; G R Greenberg; J Koval; C J Wong; M Hopkins; S B Hanauer; J W McDonald
Journal:  N Engl J Med       Date:  2000-06-01       Impact factor: 91.245

2.  Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease.

Authors:  H S Te; T D Schiano; S F Kuan; S B Hanauer; H S Conjeevaram; A L Baker
Journal:  Am J Gastroenterol       Date:  2000-11       Impact factor: 10.864

3.  The absorption of low-dose methotrexate in patients with inflammatory bowel disease.

Authors:  M Moshkowitz; R Oren; M Tishler; F M Konikoff; E Graff; S Brill; M Yaron; T Gilat
Journal:  Aliment Pharmacol Ther       Date:  1997-06       Impact factor: 8.171

4.  Low-dose oral methotrexate in refractory inflammatory bowel disease.

Authors:  T H Baron; C D Truss; C O Elson
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

5.  Methotrexate in Crohn's disease: long-term efficacy and toxicity.

Authors:  M Lémann; T Zenjari; Y Bouhnik; J Cosnes; B Mesnard; J C Rambaud; R Modigliani; A Cortot; J F Colombel
Journal:  Am J Gastroenterol       Date:  2000-07       Impact factor: 10.864

Review 6.  Review article: methotrexate in gastroenterology--dangerous villain or simply misunderstood?

Authors:  H Tang; J Neuberger
Journal:  Aliment Pharmacol Ther       Date:  1996-12       Impact factor: 8.171

7.  Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis.

Authors:  R A Hamilton; J M Kremer
Journal:  Br J Rheumatol       Date:  1997-01

8.  Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.

Authors:  B G Feagan; J Rochon; R N Fedorak; E J Irvine; G Wild; L Sutherland; A H Steinhart; G R Greenberg; R Gillies; M Hopkins
Journal:  N Engl J Med       Date:  1995-02-02       Impact factor: 91.245

9.  Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease.

Authors:  R A Kozarek; D J Patterson; M D Gelfand; V A Botoman; T J Ball; K R Wilske
Journal:  Ann Intern Med       Date:  1989-03-01       Impact factor: 25.391
  9 in total
  1 in total

Review 1.  Current therapy of pediatric Crohn's disease.

Authors:  Avishay Lahad; Batia Weiss
Journal:  World J Gastrointest Pathophysiol       Date:  2015-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.